.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
QuintilesIMS
Novartis
Colorcon
AstraZeneca
Covington
Citi
McKesson
Merck
US Department of Justice

Generated: September 23, 2017

DrugPatentWatch Database Preview

NESACAINE-MPF Drug Profile

« Back to Dashboard

Which patents cover Nesacaine-mpf, and when can generic versions of Nesacaine-mpf launch?

Nesacaine-mpf is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in NESACAINE-MPF is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.

Summary for Tradename: NESACAINE-MPF

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Clinical Trials: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NESACAINE-MPF at DailyMed

Pharmacology for Tradename: NESACAINE-MPF

Ingredient-typeEsters
Drug ClassEster Local Anesthetic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA >Approval Date TE Type RLD RS Patent No. >Patent Expiration Product Substance Delist Req. >Exclusivity Expiration
Fresenius Kabi Usa
NESACAINE-MPF
chloroprocaine hydrochloride
INJECTABLE;INJECTION009435-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
NESACAINE-MPF
chloroprocaine hydrochloride
INJECTABLE;INJECTION009435-007May 2, 1996APRXYesYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
NESACAINE-MPF
chloroprocaine hydrochloride
INJECTABLE;INJECTION009435-006May 2, 1996APRXYesYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
NESACAINE-MPF
chloroprocaine hydrochloride
INJECTABLE;INJECTION009435-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Novartis
US Department of Justice
Covington
Cipla
Moodys
Chubb
Harvard Business School
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot